В Г Иванов

679 total citations
26 papers, 492 citations indexed

About

В Г Иванов is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, В Г Иванов has authored 26 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in В Г Иванов's work include Breast Cancer Treatment Studies (11 papers), Cancer Treatment and Pharmacology (8 papers) and Advanced Breast Cancer Therapies (7 papers). В Г Иванов is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Cancer Treatment and Pharmacology (8 papers) and Advanced Breast Cancer Therapies (7 papers). В Г Иванов collaborates with scholars based in Russia, Germany and India. В Г Иванов's co-authors include Semiglazov Vf, В. В. Семиглазов, Р. М. Палтуев, А. А. Божок, Lev M. Berstein, G. A. Dashyan, Ольга Александровна Мельникова, E.K. Ziltsova, О. А. Иванова and Alexey Manikhas and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

В Г Иванов

18 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
В Г Иванов Russia 7 341 333 150 104 95 26 492
Hee‐Chul Shin South Korea 10 168 0.5× 285 0.9× 45 0.3× 181 1.7× 107 1.1× 22 579
D Morrone Italy 12 210 0.6× 141 0.4× 71 0.5× 190 1.8× 48 0.5× 23 420
Vicky Majpruz Canada 10 249 0.7× 97 0.3× 81 0.5× 47 0.5× 84 0.9× 18 389
R. Jared Weinfurtner United States 9 183 0.5× 124 0.4× 53 0.4× 109 1.0× 74 0.8× 34 452
J Dewar United Kingdom 10 164 0.5× 95 0.3× 53 0.4× 33 0.3× 94 1.0× 16 311
Brenda Rosales Australia 7 181 0.5× 203 0.6× 24 0.2× 42 0.4× 89 0.9× 27 366
Wende Logan-Young United States 10 131 0.4× 134 0.4× 123 0.8× 158 1.5× 192 2.0× 16 658
Elias Nasser Australia 9 274 0.8× 296 0.9× 40 0.3× 137 1.3× 61 0.6× 23 542
Vincenzo Marra Italy 7 126 0.4× 196 0.6× 66 0.4× 212 2.0× 78 0.8× 11 580
LFAG Massuger Netherlands 6 113 0.3× 126 0.4× 162 1.1× 151 1.5× 20 0.2× 9 457

Countries citing papers authored by В Г Иванов

Since Specialization
Citations

This map shows the geographic impact of В Г Иванов's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by В Г Иванов with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites В Г Иванов more than expected).

Fields of papers citing papers by В Г Иванов

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by В Г Иванов. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by В Г Иванов. The network helps show where В Г Иванов may publish in the future.

Co-authorship network of co-authors of В Г Иванов

This figure shows the co-authorship network connecting the top 25 collaborators of В Г Иванов. A scholar is included among the top collaborators of В Г Иванов based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with В Г Иванов. В Г Иванов is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Иванов, В Г, et al.. (2023). Effects of rotating electric fields on liver biopolymers: an experimental study. Ekologiya Cheloveka (Human Ecology). 30(2). 129–138.
2.
Иванов, В Г, et al.. (2022). Evaluation of indicators of carbohydrate and lipid metabolism in rats depending on the type of high-calorie diet. SHILAP Revista de lepidopterología. 19(1). 47–52.
3.
Vf, Semiglazov, В. В. Семиглазов, G. A. Dashyan, et al.. (2018). NEOADJUVANT ENDOCRINE THERAPY FOR PATIENTS WITH ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER. Siberian Journal of Oncology. 17(3). 11–19. 2 indexed citations
4.
Semiglazov, Vladimir, В Г Иванов, О. А. Иванова, et al.. (2017). NEOADJUVANT SYSTEMIC THERAPY FOR BREAST CANCER (RETROSPECTIVE AND PROSPECTIVE ANALYSIS). Voprosy Onkologii. 63(2). 256–260. 1 indexed citations
5.
Ziltsova, E.K., et al.. (2017). Can the androgen receptor blocking become the basis of a new method of treatment of triple negative breast cancer?. Malignant tumours. 18–25. 1 indexed citations
6.
Vf, Semiglazov, et al.. (2016). BIOLOGICAL TUMOR SUBTYPE AS A BASIS OF ADJUVANT TREATMENT OF MALE BREAST CANCER. Malignant tumours. 10–16. 1 indexed citations
7.
Kalaev, V.V., et al.. (2016). Effect of heating conditions on flow patterns during the seeding stage of Kyropoulos sapphire crystal growth. Journal of Crystal Growth. 445. 47–52. 6 indexed citations
8.
Иванов, В Г, et al.. (2015). Evaluation criteria of neoadjuvant and adjuvant methods of treatment of breast cancer. Malignant tumours. 35–35.
9.
Семиглазов, В. В., В. В. Семиглазов, Alexey Manikhas, et al.. (2015). Неоадъювантная терапия гормонозависимого рака молочной железы. 2(2). 6–11.
10.
Иванова, О. А., et al.. (2015). Breast cancer and pregnancy: diagnosis and treatment. Malignant tumours. 14–14.
11.
Иванов, В Г, et al.. (2015). Is it possible to improve breast conserving surgery operations?. Malignant tumours. 28–28. 2 indexed citations
12.
Kalaev, V.V., et al.. (2015). 3D melt convection in sapphire crystal growth: Evaluation of physical properties. International Journal of Heat and Mass Transfer. 87. 42–48. 17 indexed citations
13.
Иванов, В Г, et al.. (2015). Effect of chondroitin sulfate on the type I collagen metabolism in the compact bone in alloxan-induced rats. Kazan medical journal. 96(5). 802–806.
14.
Vf, Semiglazov, Semiglazov Vf, В. В. Семиглазов, et al.. (2007). Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor‐positive breast cancer. Cancer. 110(2). 244–254. 224 indexed citations
15.
Семиглазов, В. В., В. В. Семиглазов, В Г Иванов, et al.. (2007). [Phase II clinical trial of neoadjuvant hormone therapy in comparison with chemotherapy of patients with breast cancer].. PubMed. 53(4). 400–8. 2 indexed citations
16.
Vf, Semiglazov, Vladimir Semiglazov, В Г Иванов, et al.. (2004). The relative efficacy of neoadjuvant endocrine therapy vs chemotherapy in postmenopausal women with ER- positive breast cancer. Journal of Clinical Oncology. 22(14_suppl). 519–519. 16 indexed citations
17.
Семиглазов, В. В., Alexey Manikhas, В. Моисеенко, et al.. (2003). [Results of a prospective randomized investigation [Russia (St.Petersburg)/WHO] to evaluate the significance of self-examination for the early detection of breast cancer].. PubMed. 49(4). 434–41. 48 indexed citations
18.
Vf, Semiglazov, О. А. Иванова, В Г Иванов, et al.. (2001). Neoadjuvant chemotherapy paclitaxel + doxorubicin (PD) vs fluorouracil + doxorubicin + cyclophosphamide (FAC) in locally advanced breast cancer: Clinical and pathological response. European Journal of Cancer. 37. S166–S167.
19.
Семиглазов, В. В., В. Моисеенко, Alexey Manikhas, et al.. (1999). [Interim results of a prospective randomized study of self-examination for early detection of breast cancer (Russia/St.Petersburg/WHO)].. PubMed. 45(3). 265–71. 54 indexed citations
20.
Vf, Semiglazov, et al.. (1996). PP-5-9 Impact of adjuvant chemotherapy in conservative treatment of breast cancer T1-2NOMO. European Journal of Cancer. 32. 36–36. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hee‐Chul Shin Breakdown of academic impact, for papers by D Morrone Breakdown of academic impact, for papers by Vicky Majpruz Breakdown of academic impact, for papers by R. Jared Weinfurtner Breakdown of academic impact, for papers by J Dewar Breakdown of academic impact, for papers by Brenda Rosales Breakdown of academic impact, for papers by Wende Logan-Young Breakdown of academic impact, for papers by Elias Nasser Breakdown of academic impact, for papers by Vincenzo Marra Breakdown of academic impact, for papers by LFAG Massuger
Rankless by CCL
2026